| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.597 | 0.002 | 0.774 | Cyclooxygenase 3 inhibitor | 0.774 0.001 CID_154699757 | CID_154699757 | |
| 0.596 | 0.006 | 0.596 | Calcium channel L-type activator | 0.455 0.048 CID_154699757 | ||
| 0.511 | 0.03 | 0.511 | Toll-Like receptor 7 agonist | |||
| 0.508 | 0.03 | 0.508 | Toll-Like receptor agonist | 0.202 0.199 CID_154699757 | ||
| 0.487 | 0.04 | 0.487 | Antiobesity | 0.268 0.141 CID_154699757 | ||
| 0.378 | 0.006 | 0.378 | Bronchodilator | 0.104 0.059 CID_154699757 | ||
| 0.419 | 0.051 | 0.419 | Calpain 2 inhibitor | |||
| 0.39 | 0.028 | 0.39 | Calcium channel activator | |||
| 0.336 | 0.01 | 0.336 | Insulin sensitizer | 0.238 0.041 CID_154699757 | ||
| 0.39 | 0.096 | 0.534 | Cyclophilin D inhibitor | 0.534 0.041 CID_154699757 | CID_154699757 | |
| 0.304 | 0.013 | 0.304 | Phospholipase A2 inhibitor | 0.247 0.024 CID_154699757 | ||
| 0.315 | 0.025 | 0.463 | Non-steroidal antiinflammatory agent | 0.463 0.008 CID_154699757 | CID_154699757 | |
| 0.298 | 0.013 | 0.298 | NADPH oxidase inhibitor | 0.234 0.025 CID_154699757 | ||
| 0.279 | 0.021 | 0.279 | Cyclooxygenase inhibitor | 0.215 0.036 CID_154699757 | ||
| 0.307 | 0.068 | 0.307 | Spasmolytic | 0.203 0.116 CID_154699757 | ||
| 0.283 | 0.047 | 0.283 | Psychostimulant | 0.153 0.114 CID_154699757 | ||
| 0.227 | 0.005 | 0.227 | Adrenaline agonist | |||
| 0.376 | 0.154 | 0.676 | Antiinflammatory | 0.676 0.035 CID_154699757 | CID_154699757 | |
| 0.31 | 0.089 | 0.527 | Transcription factor NF kappa B inhibitor | 0.527 0.04 CID_154699757 | CID_154699757 | |
| 0.29 | 0.07 | 0.29 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.261 | 0.044 | 0.339 | Peptidyltransferase inhibitor | 0.339 0.014 CID_154699757 | CID_154699757 | |
| 0.24 | 0.023 | 0.24 | Cyclooxygenase 1 inhibitor | 0.197 0.036 CID_154699757 | ||
| 0.237 | 0.022 | 0.237 | Cyclooxygenase 2 inhibitor | 0.184 0.036 CID_154699757 | ||
| 0.217 | 0.005 | 0.217 | Prostaglandin EP2 antagonist | 0.146 0.01 CID_154699757 | ||
| 0.257 | 0.049 | 0.257 | Neuropeptide Y2 antagonist | |||
| 0.252 | 0.063 | 0.252 | Cyclic AMP phosphodiesterase inhibitor | 0.23 0.074 CID_154699757 | ||
| 0.309 | 0.135 | 0.43 | Analgesic | 0.43 0.072 CID_154699757 | CID_154699757 | |
| 0.178 | 0.029 | 0.178 | Antiadrenergic | |||
| 0.157 | 0.009 | 0.157 | Amidase inhibitor | |||
| 0.176 | 0.028 | 0.176 | Adrenaline antagonist | |||
| 0.238 | 0.091 | 0.238 | Cardiotonic | |||
| 0.23 | 0.084 | 0.23 | Calpain inhibitor | |||
| 0.26 | 0.118 | 0.551 | Antithrombotic | 0.551 0.022 CID_154699757 | CID_154699757 | |
| 0.168 | 0.028 | 0.168 | Pregnane X receptor agonist | |||
| 0.143 | 0.006 | 0.143 | Beta 3 adrenoreceptor antagonist | |||
| 0.18 | 0.052 | 0.18 | Acetylcholine M1 receptor antagonist | |||
| 0.25 | 0.128 | 0.25 | Sodium/bile acid cotransporter inhibitor | |||
| 0.246 | 0.124 | 0.4 | Interleukin 2 agonist | 0.4 0.027 CID_154699757 | CID_154699757 | |
| 0.205 | 0.096 | 0.261 | Antiamyloidogenic | 0.261 0.066 CID_154699757 | CID_154699757 | |
| 0.156 | 0.049 | 0.156 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.108 | 0.004 | 0.108 | Beta 2 adrenoreceptor agonist | |||
| 0.108 | 0.015 | 0.108 | Prostaglandin antagonist | |||
| 0.141 | 0.05 | 0.141 | Acetylcholine muscarinic antagonist | |||
| 0.103 | 0.012 | 0.103 | NMDA 2A receptor antagonist | |||
| 0.177 | 0.089 | 0.182 | Anesthetic general | 0.182 0.085 CID_154699757 | CID_154699757 | |
| 0.209 | 0.121 | 0.209 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.101 | 0.015 | 0.101 | Cannabinoid CB2 receptor antagonist | |||
| 0.197 | 0.115 | 0.417 | Hypoglycemic | 0.417 0.025 CID_154699757 | CID_154699757 | |
| 0.201 | 0.12 | 0.264 | Interleukin agonist | 0.264 0.069 CID_154699757 | CID_154699757 | |
| 0.099 | 0.018 | 0.099 | Acetylcholine M5 receptor antagonist | |||
| 0.085 | 0.004 | 0.085 | Beta adrenoreceptor agonist | |||
| 0.096 | 0.018 | 0.096 | Beta adrenoreceptor antagonist | |||
| 0.149 | 0.078 | 0.186 | Diuretic | 0.186 0.05 CID_154699757 | CID_154699757 | |
| 0.143 | 0.075 | 0.143 | Adenylate cyclase stimulant | |||
| 0.152 | 0.087 | 0.152 | Mcl-1 antagonist | |||
| 0.081 | 0.017 | 0.081 | Beta 1 adrenoreceptor antagonist | |||
| 0.167 | 0.106 | 0.167 | Interleukin antagonist | |||
| 0.092 | 0.032 | 0.092 | Cannabinoid receptor antagonist | |||
| 0.093 | 0.035 | 0.093 | Histidine decarboxylase inhibitor | |||
| 0.076 | 0.021 | 0.076 | Prostaglandin E2 antagonist | |||
| 0.078 | 0.027 | 0.078 | Acetylcholine M3 receptor antagonist | |||
| 0.068 | 0.018 | 0.068 | Beta 2 adrenoreceptor antagonist | |||
| 0.082 | 0.036 | 0.082 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.075 | 0.03 | 0.075 | Cannabinoid CB1 receptor antagonist | |||
| 0.073 | 0.028 | 0.073 | Potassium channel Kv1.5 blocker | |||
| 0.093 | 0.052 | 0.093 | NMDA receptor antagonist | |||
| 0.091 | 0.052 | 0.091 | Interleukin 5 antagonist | |||
| 0.082 | 0.043 | 0.082 | NMDA 2 receptor antagonist | |||
| 0.113 | 0.08 | 0.113 | Cholinergic antagonist | |||
| 0.111 | 0.079 | 0.111 | Acetylcholine antagonist | |||
| 0.174 | 0.142 | 0.174 | Nitric-oxide synthase stimulant | |||
| 0.09 | 0.059 | 0.09 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.077 | 0.048 | 0.077 | GABA B receptor agonist | |||
| 0.103 | 0.075 | 0.103 | Electron transport complex I inhibitor | |||
| 0.041 | 0.015 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.096 | 0.072 | 0.096 | Urease inhibitor | |||
| 0.068 | 0.044 | 0.068 | Bcl2 antagonist | |||
| 0.071 | 0.05 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.029 | 0.012 | 0.029 | Prostaglandin D2 antagonist | |||
| 0.027 | 0.01 | 0.027 | Beta 1 adrenoreceptor agonist | |||
| 0.034 | 0.017 | 0.034 | Prostaglandin D2 agonist | |||
| 0.097 | 0.081 | 0.097 | Mucolytic | |||
| 0.067 | 0.052 | 0.067 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.098 | 0.083 | 0.131 | Multidrug resistance-associated protein 1 inhibitor | 0.131 0.038 CID_154699757 | CID_154699757 | |
| 0.026 | 0.018 | 0.026 | Prostaglandin EP4 antagonist | |||
| 0.041 | 0.034 | 0.041 | NMDA receptor subunit 3B antagonist | |||
| 0.051 | 0.046 | 0.051 | DNA helicase inhibitor | |||
| 0.077 | 0.072 | 0.077 | Ca(v)3.1 blocker | |||
| 0.101 | 0.097 | 0.101 | Estrogen antagonist | |||
| 0.011 | 0.008 | 0.011 | Beta 3 adrenoreceptor agonist | |||
| 0.069 | 0.066 | 0.069 | Somatostatin 1 agonist | |||
| 0.04 | 0.051 | 0.046 | Aldose reductase inhibitor | 0.046 0.043 CID_154699757 | CID_154699757 | |
| 0.151 | 0.164 | 0.362 | Antioxidant | 0.362 0.043 CID_154699757 | CID_154699757 | |
| 0.061 | 0.097 | 0.087 | Glycine receptor antagonist | 0.087 0.047 CID_154699757 | CID_154699757 | |
| 0.17 | 0.212 | 0.278 | Vasodilator, coronary | 0.278 0.107 CID_154699757 | CID_154699757 | |
| 0.025 | 0.068 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 CID_154699757 | CID_154699757 | |
| 0.009 | 0.064 | 0.017 | Factor IX inhibitor | 0.017 0.014 CID_154699757 | CID_154699757 | |
| 0.169 | 0.232 | 0.323 | Apoptosis antagonist | 0.323 0.07 CID_154699757 | CID_154699757 | |
| 0.122 | 0.188 | 0.327 | Free radical scavenger | 0.327 0.045 CID_154699757 | CID_154699757 | |
| 0.062 | 0.131 | 0.106 | Expectorant | 0.106 0.062 CID_154699757 | CID_154699757 | |
| 0.034 | 0.103 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 CID_154699757 | CID_154699757 | |
| 0.09 | 0.161 | 0.169 | Cell wall synthesis inhibitor | 0.169 0.048 CID_154699757 | CID_154699757 | |
| 0.112 | 0.188 | 0.146 | Hypolipemic | 0.146 0.141 CID_154699757 | CID_154699757 | |
| 0.067 | 0.149 | 0.201 | Amylase inhibitor | 0.201 0.044 CID_154699757 | CID_154699757 | |
| 0.192 | 0.285 | 0.43 | Apoptosis agonist | 0.43 0.1 CID_154699757 | CID_154699757 | |
| 0.027 | 0.12 | 0.233 | Selectin antagonist | 0.233 0.009 CID_154699757 | CID_154699757 | |
| 0.045 | 0.142 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 CID_154699757 | CID_154699757 | |
| 0.029 | 0.137 | 0.052 | Factor IXa inhibitor | 0.052 0.035 CID_154699757 | CID_154699757 | |
| 0.035 | 0.157 | 0.075 | Topoisomerase II alpha inhibitor | 0.075 0.057 CID_154699757 | CID_154699757 | |
| 0.088 | 0.212 | 0.22 | Nitric oxide antagonist | 0.22 0.061 CID_154699757 | CID_154699757 | |
| 0.063 | 0.192 | 0.192 | Thrombolytic | 0.192 0.056 CID_154699757 | CID_154699757 | |
| 0.036 | 0.168 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 CID_154699757 | CID_154699757 | |
| 0.104 | 0.239 | 0.18 | Vasodilator | 0.18 0.122 CID_154699757 | CID_154699757 | |
| 0.084 | 0.22 | 0.149 | Insulin secretagoues | 0.149 0.076 CID_154699757 | CID_154699757 | |
| 0.137 | 0.275 | 0.376 | Immunosuppressant | 0.376 0.074 CID_154699757 | CID_154699757 | |
| 0.127 | 0.266 | 0.278 | Cholesterol antagonist | 0.278 0.106 CID_154699757 | CID_154699757 | |
| 0.052 | 0.221 | 0.146 | Lipid peroxidase inhibitor | 0.146 0.071 CID_154699757 | CID_154699757 | |
| 0.032 | 0.22 | 0.11 | Topoisomerase I inhibitor | 0.11 0.062 CID_154699757 | CID_154699757 | |
| 0.08 | 0.269 | 0.273 | Platelet antagonist | 0.273 0.063 CID_154699757 | CID_154699757 | |
| 0.017 | 0.216 | 0.047 | Antibiotic Aminoglycoside-like | 0.047 0.015 CID_154699757 | CID_154699757 | |
| 0.042 | 0.249 | 0.125 | Alkylator | 0.125 0.063 CID_154699757 | CID_154699757 | |
| 0.079 | 0.292 | 0.149 | Interferon gamma antagonist | 0.149 0.079 CID_154699757 | CID_154699757 | |
| 0.014 | 0.237 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 CID_154699757 | CID_154699757 | |
| 0.068 | 0.294 | 0.26 | Hepatoprotectant | 0.26 0.041 CID_154699757 | CID_154699757 | |
| 0.052 | 0.28 | 0.134 | Cell adhesion inhibitor | 0.134 0.056 CID_154699757 | CID_154699757 | |
| 0.033 | 0.262 | 0.095 | Topoisomerase II inhibitor | 0.095 0.091 CID_154699757 | CID_154699757 | |
| 0.099 | 0.33 | 0.259 | Alpha-glucosidase inhibitor | 0.259 0.182 CID_154699757 | CID_154699757 | |
| 0.016 | 0.248 | 0.059 | Protein 50S ribosomal subunit inhibitor | 0.059 0.032 CID_154699757 | CID_154699757 | |
| 0.046 | 0.284 | 0.124 | Toll-Like receptor 4 antagonist | 0.124 0.04 CID_154699757 | CID_154699757 | |
| 0.051 | 0.295 | 0.188 | Anticoagulant | 0.188 0.058 CID_154699757 | CID_154699757 | |
| 0.037 | 0.29 | 0.107 | Beta glucuronidase inhibitor | 0.107 0.06 CID_154699757 | CID_154699757 | |
| 0.035 | 0.289 | 0.072 | Cell adhesion molecule inhibitor | 0.072 0.065 CID_154699757 | CID_154699757 | |
| 0.062 | 0.319 | 0.235 | Platelet adhesion inhibitor | 0.235 0.055 CID_154699757 | CID_154699757 | |
| 0.063 | 0.326 | 0.145 | NOS3 expression enhancer | 0.145 0.077 CID_154699757 | CID_154699757 | |
| 0.057 | 0.326 | 0.269 | Immunostimulant | 0.269 0.089 CID_154699757 | CID_154699757 | |
| 0.114 | 0.388 | 0.256 | Caspase 3 stimulant | 0.256 0.107 CID_154699757 | CID_154699757 | |
| 0.009 | 0.296 | 0.08 | Antineoplastic antibiotic | 0.08 0.057 CID_154699757 | CID_154699757 | |
| 0.043 | 0.333 | 0.388 | Angiogenesis stimulant | 0.388 0.024 CID_154699757 | CID_154699757 | |
| 0.04 | 0.36 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.058 CID_154699757 | CID_154699757 | |
| 0.016 | 0.392 | 0.053 | Heparanase inhibitor | 0.053 0.036 CID_154699757 | CID_154699757 | |
| 0.046 | 0.425 | 0.119 | Hemostatic | 0.119 0.115 CID_154699757 | CID_154699757 | |
| 0.01 | 0.45 | 0.068 | DNA gyrase inhibitor | 0.068 0.038 CID_154699757 | CID_154699757 | |
| 0.05 | 0.554 | 0.484 | Antibacterial | 0.484 0.045 CID_154699757 | CID_154699757 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |